Disease · MONDO_0005477
Trials20
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 20 of 20
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01401647 | Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia | Phase 3 | 3,024 | 2017-01-30 | Cardiac Arrest | AMIODARONE, LIDOCAINE | Its record names the disease | ClinicalTrials.gov |
| NCT01215253 | Ranolazine Implantable Cardioverter-Defibrillator Trial | Phase 3 | 1,012 | 2018-06-15 | Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy, Heart Failure | RANOLAZINE | Its record names the disease | ClinicalTrials.gov |
| NCT04134845 | A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias. | Phase 2/3 | 68 | 2025-08-15 | Ventricular Tachycardia | DANTROLENE | Its record names the disease | ClinicalTrials.gov |
| NCT02301390 | INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events | Not applicable | 53 | 2020-01-27 | Ventricular Tachycardia | AMIODARONE | Its record names the disease | ClinicalTrials.gov |
| NCT01576042 | Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator | Not applicable | 27 | 2014-09-25 | Ventricular Tachycardia | AMIODARONE, SOTALOL | Its record names the disease | ClinicalTrials.gov |
| NCT03685149 | Pilot Randomized Trial With Flecainide in ARVC Patients | Phase 2 | 22 | 2024-08-20 | Arrhythmogenic Right Ventricular Cardiomyopathy | FLECAINIDE | Its record names the disease | ClinicalTrials.gov |
| NCT01097330 | Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia | Phase 3 | 12 | 2020-01-29 | Defibrillators, Implantable, Tachycardia, Ventricular | AMIODARONE | Its record names the disease | ClinicalTrials.gov |
| NCT02360397 | Ranolazine Mediated PVC Reduction in Ischemic Heart Disease | Phase 2 | 6 | 2020-01-29 | Ventricular Premature Complexes, Myocardial Ischemia | RANOLAZINE | Its record names the disease | ClinicalTrials.gov |
| NCT03853369 | Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection | 2,000 | Ventricular Tachycardia, Ventricular Fibrillation | NIFEKALANT | Its record names the disease | ClinicalTrials.gov | ||
| NCT06680869 | Early Amiodarone in Shockable Cardiac Arrest | Phase 3 | 585 | Cardiac Arrest | AMIODARONE HYDROCHLORIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT03734562 | Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia | Not applicable | 180 | Monomorphic Ventricular Tachycardia | AMIODARONE, SOTALOL | Its record names the disease | ClinicalTrials.gov | |
| NCT05524077 | Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia | Not applicable | 162 | Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated, Sarcoidosis, Cardiomyopathy, Hypertrophic, Cardiomyopathy Ischemic, Cardiomyopathy, Familial, Arrhythmogenic Right Ventricular Cardiomyopathy 1, Arrhythmogenic Left Ventricular Cardiomyopathy | AMIODARONE | Its record names the disease | ClinicalTrials.gov | |
| NCT05511246 | Venous Ethanol for Ventricular Tachycardia | Phase 2 | 156 | Ventricular Tachycardia, Ischemic Cardiomyopathy | ALCOHOL | Its record names the disease | ClinicalTrials.gov | |
| NCT06780215 | Efficacy of Varenicline Tartrate in Treating Frequent Premature Ventricular Contractions | Phase 2 | 116 | Premature Ventricular Contraction (PVC) | VARENICLINE, VARENICLINE TARTRATE | Its record names the disease | ClinicalTrials.gov | |
| NCT06669299 | Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies | Not applicable | 51 | Ventricular Tachycardia (VT) | AMIODARONE, MEXILETINE, SOTALOL | Its record names the disease | ClinicalTrials.gov | |
| NCT05619120 | The Effect of Late Na Current Blocker Mexiletine on Giant T-wave Electrical Alternans(STOP-TWA) | Not applicable | 50 | Giant T-wave Electrical Alternans | MEXILETINE | Its record names the disease | ClinicalTrials.gov | |
| NCT07566208 | Using Mirabegron to Control Arrhythmia-1 | Phase 2 | 20 | Ventricular Arrhythmias and Cardiac Arrest | MIRABEGRON | Its record names the disease | ClinicalTrials.gov | |
| NCT00721032 | Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia | Not applicable | 0 | Ventricular Tachycardia | AMIODARONE | Its record names the disease | ClinicalTrials.gov | |
| NCT01798277 | Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia | Phase 3 | 0 | Ventricular Tachycardia, Coronary Artery Disease | AMIODARONE, SOTALOL | Its record names the disease | ClinicalTrials.gov | |
| NCT00000518 | Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) | Phase 3 | Arrhythmia, Cardiovascular Diseases, Death, Sudden, Cardiac, Heart Diseases, Tachycardia, Ventricular, Ventricular Arrhythmia, Ventricular Fibrillation | IMIPRAMINE, MEXILETINE, PROCAINAMIDE, QUINIDINE, SOTALOL | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005477/trials